PD-1 Inhibitor Therapy in Adult T-Cell Leukemia–Lymphoma
N Engl J Med
.
2018 Aug 16;379(7):696.
doi: 10.1056/NEJMc1807852.
Authors
Keisuke Kataoka
1
,
Seishi Ogawa
2
Affiliations
1
National Cancer Center Research Institute, Tokyo, Japan
2
Kyoto University, Kyoto, Japan sogawa-tky@umin.ac.jp
PMID:
30124280
DOI:
10.1056/NEJMc1807852
No abstract available
Publication types
Letter
Comment
MeSH terms
Adult
B7-H1 Antigen
Humans
Leukemia-Lymphoma, Adult T-Cell*
Programmed Cell Death 1 Receptor*
Substances
B7-H1 Antigen
Programmed Cell Death 1 Receptor